Pimavanserin

Overview

Pimavanserin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2111101).

API suppliers (1)

Suppliers of Pimavanserin backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• LIVZON NEW NORTH RIVER PHARMACEUTICAL CO LTDChina

Patent & exclusivity (US)

Per the FDA Orange Book (2 approved US products), the latest listed US patent on Pimavanserin expires 27 Feb 2039 and exclusivity 27 Oct 2029. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

1-[(4-fluorophenyl)methyl]-1-(1-methylpiperidin-4-yl)-3-[[4-(2-methylpropoxy)phenyl]methyl]urea

Canonical SMILES

CC(C)COC1=CC=C(C=C1)CNC(=O)N(CC2=CC=C(C=C2)F)C3CCN(CC3)C

InChIKey

RKEWSXXUOLRFBX-UHFFFAOYSA-N